212-681-1575

Boehringer Ingelheim has announced that the UK is following in the footsteps of the U.S. in the latest designation for the company’s drug nintedanib. In December 2016, the U.S. Food and Drug Administration granted orphan drug designation to the investigational ...
Continue Reading

Want Specific topic updates?

Many mesothelioma patients may not know that every day the National Organization for Rare Disorders has a team of people fighting for them. NORD was established in 1983 to improve ...

Read Full Story

Want Specific topic updates?

Mesothelioma patients often lose ground when fighting back against the deadly cancer due to a compromised immune system. Immunotherapy is one way oncologists and researchers use to ...

Read Full Story

Want Specific topic updates?

The doctors at Libby, Montana’s Center for Asbestos Related Disease (CARD) know a thing or two about mesothelioma. The town is home to a vermiculite mine blamed for widesprea ...

Read Full Story

Want Specific topic updates?

laboratory

Patients, physicians and researchers in the mesothelioma community suffered a serious setback last month when Aduro Biotech announced they terminated the Phase Ib clinical trial fo ...

Read Full Story

Want Specific topic updates?

1 2 3 50